This is additional taxonomy that helps us with analytics
The drug is used to treat toxoplasmosis, a parasitic infection that threatens people with weakened immune systems.The non-jury trial will take place before U.S. District Judge Denise Cote in Manhattan federal court. Christopher Casey, a lawyer for Shkreli, could not immediately be reached for comment on Monday.
Vyera, founded in 2014 as Turing Pharmaceuticals, acquired Daraprim from Impax Laboratories Inc in 2015.The FTC and states allege that the company then prevented generic drugmakers from obtaining samples to develop their own versions of the drug, and reached a deal with the sole U.S. supplier of the drug’s active ingredient preventing sales to competitors.
They said the company’s actions violated federal antitrust laws and harmed patients. The first generic version of Daraprim was approved in 2020.. The deal calls for Vyera to pay $10 million up front plus up to $30 million over 10 years, and bans Mulleady from most roles in the pharmaceutical industry for seven years.for cheating investors in two hedge funds and trying to prop up the stock price of another drug company he led, Retrophin Inc. He is eligible for release next year.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Vifor Pharma shares jump 15% as takeover talks with CSL confirmedVifor Pharma's shares surged more than 15% in early trading on Monday after the Swiss drugmaker and Australia's CSL both confirmed they were talking about a potential merger.
Weiterlesen »
CSL Makes US$11.7 Billion Offer for Switzerland's Vifor PharmaBy Stuart Condie SYDNEY--Australian biopharmaceutical company CSL Ltd. said it had made an all-cash offer for Vifor Pharma Ltd. that values the Swiss...
Weiterlesen »
Michael Bay, Kanye West Biopics Among 2021 Black List ScreenplaysScreenplays about Dennis Rodman and 'pharma bro' Martin Shkreli also make an appearance on this year's list.
Weiterlesen »
Netflix Slashes India Subscription Price as Amazon Prime Video Hikes its RatesIn a bid to capture a bigger share of the large, fiercely competitive and price-sensitive Indian streaming market, Netflix has sharply reduced its subscription price plans in the territory. The che…
Weiterlesen »
CSL Makes US$11.7 Billion Offer for Switzerland's Vifor PharmaBy Stuart Condie SYDNEY--Australian biopharmaceutical company CSL Ltd. said it had made an all-cash offer for Vifor Pharma Ltd. that values the Swiss...
Weiterlesen »
Vifor Pharma shares jump 15% as takeover talks with CSL confirmedVifor Pharma's shares surged more than 15% in early trading on Monday after the Swiss drugmaker and Australia's CSL both confirmed they were talking about a potential merger.
Weiterlesen »